Compare AKRO & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKRO | HDL |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 1.1B |
| IPO Year | 2019 | 2024 |
| Metric | AKRO | HDL |
|---|---|---|
| Price | $54.65 | $17.35 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $73.56 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 2.1K |
| Earning Date | 11-07-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $820,865,000.00 |
| Revenue This Year | N/A | $11.19 |
| Revenue Next Year | N/A | $13.37 |
| P/E Ratio | ★ N/A | $438.76 |
| Revenue Growth | N/A | ★ 8.02 |
| 52 Week Low | $21.34 | $16.30 |
| 52 Week High | $58.40 | $30.00 |
| Indicator | AKRO | HDL |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 45.84 |
| Support Level | $54.30 | $16.70 |
| Resistance Level | $54.70 | $18.33 |
| Average True Range (ATR) | 0.17 | 0.29 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 71.07 | 39.88 |
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.